How many institutions held AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share in Q1 2023?

31 institutional investors reported AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share for Q1 2023. Use the holders table for investor-level position and value details.

AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI)

Q: What does CUSIP 00901B105 represent in this 13F holders report?

CUSIP 00901B105 is the security identifier for AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 00901B105

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 4,759,372
Total 13F value: $2,047,309
Share change: -600,243
SEC-reported price per share: $0.43
Number of holders: 31
Value change: -$250,545
Number of buys: 8
Number of sells: 13
Shares outstanding: 18,121,202

Security key

00901B105

Report period

Q1 2023

Institutions

Top holders

AIMI full security history Ownership snapshot Full 13F holder table AIM ImmunoTech Inc. SEC filings AIM ImmunoTech Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VANGUARD GROUP INC

Disclosed value leader

VANGUARD GROUP INC

Comparable rows

15/15

Latest evidence

31 Dec 2022

13F Lead comparable stake: 11% Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.

Comparable ownership Top 5

VANGUARD GROUP INC 11%

MORGAN STANLEY 5.1%

BlackRock Finance, Inc. 4.5%

GEODE CAPITAL MANAGEMENT, LLC 2.1%

STATE STREET CORP 0.96%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	11%	$620,277 1,988,704 shares	—	31 Dec 2022
MORGAN STANLEY	13F Company 13F	5.1%	$285,903 916,649 shares	—	31 Dec 2022
BlackRock Finance, Inc.	13F Company 13F	4.5%	$253,801 813,726 shares	—	31 Dec 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	2.1%	$118,000 380,905 shares	—	31 Dec 2022
STATE STREET CORP	13F Company 13F	0.96%	$53,991 173,103 shares	—	31 Dec 2022
Verition Fund Management LLC	13F Company 13F	0.84%	$47,721 153,000 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

4,759,372

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %